Labcorp Holdings Free Cash Flow 2010-2025 | LH
Labcorp Holdings annual/quarterly free cash flow history and growth rate from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Labcorp Holdings free cash flow for the quarter ending March 31, 2025 was -107.00, a year-over-year.
- Labcorp Holdings free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.
- Labcorp Holdings annual free cash flow for 2024 was $1.098B, a 25.52% increase from 2023.
- Labcorp Holdings annual free cash flow for 2023 was $0.875B, a 42.76% decline from 2022.
- Labcorp Holdings annual free cash flow for 2022 was $1.528B, a 44.94% decline from 2021.
| Labcorp Holdings Annual Free Cash Flow | |
|---|---|
| 2024 | 1,097.90 |
| 2023 | 874.70 |
| 2022 | 1,528.00 |
| 2021 | 2,775.40 |
| 2020 | 1,795.70 |
| 2019 | 1,052.20 |
| 2018 | 975.70 |
| 2017 | 1,190.70 |
| 2016 | 949.00 |
| 2015 | 727.20 |
| 2014 | 536.90 |
| 2013 | 617.60 |
| 2012 | 670.80 |
| 2011 | 713.60 |
| 2010 | 762.30 |
| 2009 | 748.60 |
| Labcorp Holdings Quarterly Free Cash Flow | |
|---|---|
| 2025-03-31 | -107.00 |
| 2024-12-31 | 1,097.90 |
| 2024-09-30 | 431.40 |
| 2024-06-30 | 269.50 |
| 2024-03-31 | -163.50 |
| 2023-12-31 | 874.70 |
| 2023-09-30 | 462.00 |
| 2023-06-30 | 291.30 |
| 2023-03-31 | 43.10 |
| 2022-12-31 | 1,528.00 |
| 2022-09-30 | 973.30 |
| 2022-06-30 | 682.20 |
| 2022-03-31 | 239.80 |
| 2021-12-31 | 2,775.40 |
| 2021-09-30 | 2,105.20 |
| 2021-06-30 | 1,454.90 |
| 2021-03-31 | 1,064.80 |
| 2020-12-31 | 1,795.70 |
| 2020-09-30 | 1,079.50 |
| 2020-06-30 | 376.60 |
| 2020-03-31 | 104.20 |
| 2019-12-31 | 1,052.20 |
| 2019-09-30 | 608.70 |
| 2019-06-30 | 244.10 |
| 2019-03-31 | 75.50 |
| 2018-12-31 | 975.70 |
| 2018-09-30 | 611.50 |
| 2018-06-30 | 408.10 |
| 2018-03-31 | 107.30 |
| 2017-12-31 | 1,190.70 |
| 2017-09-30 | 717.50 |
| 2017-06-30 | 395.90 |
| 2017-03-31 | 154.50 |
| 2016-12-31 | 949.00 |
| 2016-09-30 | 546.30 |
| 2016-06-30 | 360.00 |
| 2016-03-31 | 58.70 |
| 2015-12-31 | 727.20 |
| 2015-09-30 | 427.60 |
| 2015-06-30 | 207.40 |
| 2015-03-31 | -120.40 |
| 2014-12-31 | 536.90 |
| 2014-09-30 | 369.00 |
| 2014-06-30 | 245.40 |
| 2014-03-31 | 86.00 |
| 2013-12-31 | 617.60 |
| 2013-09-30 | 428.00 |
| 2013-06-30 | 245.70 |
| 2013-03-31 | 156.70 |
| 2012-12-31 | 670.80 |
| 2012-09-30 | 477.70 |
| 2012-06-30 | 316.60 |
| 2012-03-31 | 163.40 |
| 2011-12-31 | 713.60 |
| 2011-09-30 | 465.00 |
| 2011-06-30 | 328.10 |
| 2011-03-31 | 186.30 |
| 2010-12-31 | 762.30 |
| 2010-09-30 | 535.00 |
| 2010-06-30 | 391.60 |
| 2010-03-31 | 209.10 |
| 2009-12-31 | 748.60 |
| 2009-09-30 | 561.50 |
| 2009-06-30 | 337.10 |
| 2009-03-31 | 178.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $21.878B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.155B | 26.10 |
| Elevance Health (ELV) | United States | $84.931B | 10.96 |
| CVS Health (CVS) | United States | $84.554B | 10.51 |
| Cencora (COR) | United States | $57.517B | 20.01 |
| Natera (NTRA) | United States | $23.347B | 0.00 |
| DiDi Global (DIDIY) | China | $22.403B | 23.80 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.676B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| CochLear (CHEOY) | Australia | $12.083B | 0.00 |
| ICON (ICLR) | Ireland | $11.595B | 10.78 |
| Revvity (RVTY) | United States | $11.128B | 19.15 |
| Doximity (DOCS) | United States | $10.714B | 49.60 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| HealthEquity (HQY) | United States | $8.820B | 38.64 |
| Medpace Holdings (MEDP) | United States | $8.700B | 23.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.407B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.136B | 13.98 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.085B | 24.06 |
| BrightSpring Health Services (BTSG) | United States | $3.934B | 36.10 |
| Sotera Health (SHC) | United States | $3.105B | 17.65 |
| Alignment Healthcare (ALHC) | United States | $2.849B | 0.00 |
| Concentras Parent (CON) | United States | $2.676B | 15.47 |
| Organon (OGN) | United States | $2.568B | 2.73 |
| Surgery Partners (SGRY) | United States | $2.542B | 33.06 |
| PACS (PACS) | United States | $2.027B | 0.00 |
| Progyny (PGNY) | United States | $1.856B | 40.85 |
| Ardent Health (ARDT) | United States | $1.854B | 7.90 |
| GeneDx Holdings (WGS) | United States | $1.838B | 70.80 |
| Premier (PINC) | United States | $1.834B | 13.92 |
| GoodRx Holdings (GDRX) | United States | $1.600B | 32.00 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.147B | 8.73 |
| Establishment Labs Holdings (ESTA) | $1.100B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.856B | 8.01 |
| QDM (QDMI) | Hong Kong, SAR China | $0.758B | 0.00 |
| LifeMD (LFMD) | United States | $0.684B | 0.00 |
| Nutex Health (NUTX) | United States | $0.661B | 10.01 |
| Embecta (EMBC) | United States | $0.569B | 3.83 |
| InnovAge Holding (INNV) | United States | $0.512B | 0.00 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Enhabit (EHAB) | United States | $0.473B | 38.92 |
| Auna S.A (AUNA) | Luxembourg | $0.459B | 10.33 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Omada Health (OMDA) | $0.399B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.267B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.119B | 0.00 |
| So-Young (SY) | China | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |